H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

C. difficile spores are highly resistant to desiccation, chemicals and extreme temperature. Spores frequently contaminate the environment around patients with CDI, potentially persisting for ...

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

Therefore, new therapeutic or strategies already available for treatment of CDI have two goals: eradicating the infection, despite the continuation of concomitant therapy, and reducing the ...

St. Louis-based Washington University School of Medicine researchers found that fidaxomicin, a treatment for Clostridioides difficile infection, has increased in use but "remains underutilized." ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

We’ve rounded up a selection of topical, over-the-counter treatments to help alleviate the symptoms of fungal nail infections. Help to destroy the problem at its source with this 3-in-1 shoe ...

She led CDC activities to detect and prevent infections in healthcare settings ... and developing innovative microbiome therapeutics and treatments for inflammatory bowel disease (IBD).

Lee said. But patients often go untreated for years — either because they don’t realize their infection is serious and requires treatment, or because they lose contact with the health system.

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

The suspect: a vaginal yeast infection. But there was some mystery, too. The patient had used a one-day, over-the-counter treatment for the problem. Why was she still in pain a week later?